Empery Asset Management, LP 13D and 13G filings for Caladrius Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-19 10:44 am Sale | 2021-12-31 | 13G | Caladrius Biosciences, Inc. CLBS | Empery Asset Management, LP | 167,024 4.020% | -62,908 (-27.36%) | Filing |
| 2021-02-18 10:54 am Purchase | 2021-02-12 | 13G | Caladrius Biosciences, Inc. CLBS | Empery Asset Management, LP | 229,932 5.900% | 229,932 (New Position) | Filing |